Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss treatments work better with lifestyle changes.

Premature hair graying may be a sign of increased risk for heart disease, indicating biological age is more important than actual age.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

High aldosterone and free testosterone levels link to female hair loss; testing aldosterone may predict hypertension risk.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Beard cells, unlike scalp cells, produce growth factors in response to testosterone, which may explain differences in hair growth.

Finasteride and dutasteride might lower melanoma risk.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Hormones like testosterone affect skin functions and can cause skin issues when in excess; treatments to manage these effects are only somewhat effective.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Obesity may worsen hair loss in men and increase hirsutism in overweight or obese individuals, with weight loss recommended for treatment.

Women with PCOS have altered brain structure and reduced cognitive performance.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Mouse genital development depends on male or female hormones for specific features.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.